Allen Susan S - OmicsDI

Show results for

Unknown (30)
Genomics (3)
Proteomics (2)
Transcriptomics (1)
Metabolomics (1)

Organisms

Homo sapiens (3)
Vitis vinifera (1)
Bos taurus (1)

Repository

EGA (3)
biostudies-arrayexpress (1)
MassIVE (1)
MetaboLights (1)
PanoramaPublic (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2015 (1)
2013 (1)
2025 (1)

Metabolite Name

CE 18:0 (1)
Cer 34:0;2O (1)
Cer 34:1;2O|Cer 18:1;2O/16:0 (1)
Cer 36:1;2O (1)
Cer 38:0;3O (1)
Cer 40:0;2O|Cer 18:0;2O/22:0 (1)
Cer 40:1;2O|Cer 18:1;2O/22:0 (1)
Cer 40:2;2O|Cer 18:1;2O/22:1 (1)
Cer 42:0;2O|Cer 18:0;2O/24:0 (1)
Cer 42:0;3O|Cer 18:0;2O/24:0;O (1)
Cer 42:1;2O|Cer 18:1;2O/24:0 (1)
Cer 43:1;2O|Cer 18:1;2O/25:0 (1)
DG 32:0|DG 16:0_16:0 (1)
DG 34:0|DG 16:0_18:0 (1)
DG 36:1|DG 18:0_18:1 (1)
Hydroxyvitamin D3 (1)
LPE O-16:1 (1)
LPE O-18:1 (1)
N-Palmitoyl Lisine (1)
PC 27:0 (1)
PC O-36:1|PC O-18:0_18:1 (1)
PS 36:2|PS 18:1_18:1 (1)
PS 38:4|PS 18:0_20:4 (1)
PS 40:6|PS 18:0_22:6 (1)
ST 27:2;O_1 (1)
ST 27:2;O_2 (1)
ST 27:2;O_3 (1)
Stearoylcarnitine (1)
TG 44:1|TG 12:0_14:0_18:1 (1)
TG 46:1|TG 14:0_16:0_16:1 (1)

Study type

RNA-seq of coding RNA (1)

Release Date

2023 (6)
2025 (5)
2021 (5)
2024 (3)
2022 (3)
2015 (2)
2026 (2)
2019 (2)
2020 (1)
2017 (1)
2013 (1)

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.

Not available

S-EPMC3577951 | biostudies-literature

Design, Implementation and Multisite Evaluation of a System Suitability Protocol for the Quantitative Assessment of Instrument Performance in Liquid Chromatography-Multiple Reaction Monitoring-MS (LC-MRM-MS)

Multiple reaction monitoring (MRM) mass spectrometry coupled with stable isotope dilution (SID) and liquid chromatography (LC) is increasingly used in biological and clinical studies for precise and reproducible quantification of peptides and proteins in complex sample matrices. Robust LC-SID-MRM-MS...

ORGANISM(S): Bos Taurus

PXD010535 | panorama

Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer.

Not available

S-EPMC12663104 | biostudies-literature

Structure of the complete Saccharomyces cerevisiae Rpd3S-nucleosome complex.

Not available

S-EPMC10709384 | biostudies-literature

Gamma-induction in frontotemporal dementia (GIFTeD) randomized placebo-controlled trial: Rationale, noninvasive brain stimulation protocol, and study design.

Not available

S-EPMC8813035 | biostudies-literature

Blood Pressure Polygenic Score Predicts Long-Term Blood Pressure Control and Treatment-Resistant Hypertension.

Not available

S-EPMC12805946 | biostudies-literature

Developmental and metabolic plasticity of ripe Semillon grape berries in response to Botrytis cinerea during noble rot

Noble rot results from atypical infections of ripe grape berries by Botrytis cinerea. Unlike bunch rot, noble rot promotes favorable changes in grape berries and accumulation of secondary metabolites that enhance wine grape quality. Noble rot-infected berries of SÃ©millon, a white-skinned variety, w...

ORGANISM(S): Vitis vinifera

2015-10-12 | E-GEOD-67932 | biostudies-arrayexpress

Chromatin Potential Identified by Shared Single-Cell Profiling of RNA and Chromatin.

Not available

S-EPMC7669735 | biostudies-literature

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

Not available

S-EPMC4486345 | biostudies-literature

Genomic profiling of ER⁺ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance.

Not available

S-EPMC5723145 | biostudies-literature